CytomX Therapeutics Inc

NASDAQ:CTMX   3:59:51 PM EDT
1.63
-0.06 (-3.55%)
Earnings Announcements

Cytomx Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/05/2022 21:00 GMT
CytomX Therapeutics Inc (CTMX) - Cytomx Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Qtrly Basic and Diluted Net Loss per Share $0.37.
Q1 Earnings per Share View $-0.36 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $19.45 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $19.62 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.